These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 15098008

  • 1. Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma.
    Takahashi Y, Oda Y, Kawaguchi K, Tamiya S, Yamamoto H, Suita S, Tsuneyoshi M.
    Mod Pathol; 2004 Jun; 17(6):660-9. PubMed ID: 15098008
    [Abstract] [Full Text] [Related]

  • 2. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y, Sakamoto A, Satio T, Kawauchi S, Iwamoto Y, Tsuneyoshi M.
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
    Kanavaros P, Bai M, Stefanaki K, Poussias G, Rontogianni D, Zioga E, Gorgoulis V, Agnantis NJ.
    Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692
    [Abstract] [Full Text] [Related]

  • 4. Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
    Naka T, Boltze C, Kuester D, Schulz TO, Schneider-Stock R, Kellner A, Samii A, Herold C, Ostertag H, Roessner A.
    Cancer; 2005 Sep 15; 104(6):1255-63. PubMed ID: 16078265
    [Abstract] [Full Text] [Related]

  • 5. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.
    Møller MB, Kania PW, Ino Y, Gerdes AM, Nielsen O, Louis DN, Skjødt K, Pedersen NT.
    Leukemia; 2000 May 15; 14(5):898-904. PubMed ID: 10803523
    [Abstract] [Full Text] [Related]

  • 6. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E, Michael M, Stavropoulos NE, Kitsiou E, Hastazeris K, Salmas M, Stefanaki S, Agnantis NJ.
    Urol Int; 2004 May 15; 73(1):65-73. PubMed ID: 15263796
    [Abstract] [Full Text] [Related]

  • 7. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.
    Park HR, Jung WW, Bertoni F, Bacchini P, Park JH, Kim YW, Park YK.
    Pathol Res Pract; 2004 May 15; 200(6):439-45. PubMed ID: 15310147
    [Abstract] [Full Text] [Related]

  • 8. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
    Kawaguchi K, Oda Y, Sakamoto A, Saito T, Tamiya S, Iwamoto Y, Tsuneyoshi M.
    Mod Pathol; 2002 Aug 15; 15(8):878-88. PubMed ID: 12181274
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: correlation with cyclin-D1 immunoreactivity.
    Lai R, Medeiros LJ, Wilson CS, Sun NC, Koo C, McCourty A, Brynes RK.
    Mod Pathol; 1998 Jul 15; 11(7):642-7. PubMed ID: 9688185
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior.
    Staibano S, Franco R, Tranfa F, Mezza E, Lo Muzio L, Strianese D, Errico ME, Bufo P, Ferrara G, Somma P, Mansueto G, Greco I, Fiorillo A, Bonavolontà G, De Rosa G.
    Anticancer Res; 2004 Jul 15; 24(1):249-57. PubMed ID: 15015604
    [Abstract] [Full Text] [Related]

  • 14. p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study.
    Leuschner I, Langhans I, Schmitz R, Harms D, Mattke A, Treuner J, Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study.
    Pediatr Dev Pathol; 2003 Jul 15; 6(2):128-36. PubMed ID: 12574910
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas.
    Skomedal H, Kristensen GB, Lie AK, Holm R.
    Gynecol Oncol; 1999 May 15; 73(2):223-8. PubMed ID: 10329038
    [Abstract] [Full Text] [Related]

  • 17. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
    Bilyk OO, Pande NT, Buchynska LG.
    Exp Oncol; 2011 Sep 15; 33(3):150-6. PubMed ID: 21956468
    [Abstract] [Full Text] [Related]

  • 18. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines.
    Taylor AC, Shu L, Danks MK, Poquette CA, Shetty S, Thayer MJ, Houghton PJ, Harris LC.
    Med Pediatr Oncol; 2000 Aug 15; 35(2):96-103. PubMed ID: 10918230
    [Abstract] [Full Text] [Related]

  • 19. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
    Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C.
    Am J Pathol; 1998 Dec 15; 153(6):1749-65. PubMed ID: 9846966
    [Abstract] [Full Text] [Related]

  • 20. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
    Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N.
    Anticancer Res; 2000 Dec 15; 20(1A):337-44. PubMed ID: 10769677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.